NLRP3 and Parkinson disease: NLRP3 inflammation promotes the secretion of IL-1β and IL-18 and the formation of GSDMD pores by activating caspase 1, which leads to the apoptosis of PD brain neurons and aggravates the process of neurodegeneration [87].